International consensus statement on robotic pancreatic surgery

Liu, Rong; Wakabayashi, Go; Palanivelu, Chinnusamy; Tsung, Allan; Yang, Kehu; Goh, Brian K. P.; Chong, Charing Ching Ning; Kang, Chang Moo; Peng, Chenghong; Kakiashvili, Eli; Han, Ho‐Seong; Kim, Hong-Jin; He, Jin; Lee, Jae Hoon; Takaori, Kyoichi; Marino, Marco Vito; Wang, Shen‐Nien; Guo, Tiankang; Hackert, Thilo; Huang, Ting; Yiengpruksawan, Anusak; Fong, Yuman; Nagakawa, Yuichi; Shyr, Yi‐Ming; Wu, Yao‐Ming; Zhao, Yupei

doi:10.21037/hbsn.2019.07.08

Cited by 88 publications

(57 citation statements)

References 116 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, our department led the drafting and development of an international expert consensus on robotic pancreatic and robotic hepatectomy surgery. 25,26 Robotic surgery is as safe as laparoscopic and open surgery, with comparable intraoperative blood loss, length of hospital stay (LOS), overall postoperative complication rate, perioperative mortality, and rate of postoperative pancreatic stula (POPF) to laparoscopic surgery.…”

Section: Discussionmentioning

confidence: 99%

“…Moreover, robotic surgery has a longer operating time, less intraoperative blood loss, and shorter LOS than open surgery, whereas it has a similar overall complication rate, perioperative mortality, and POPF rate. 25 Taken together, robotic surgery has some advantages in patients with hepatobiliary pancreatic tumor, especially during COVID-19 outbreak, in that it decreases LOS and enhances recovery after surgery.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A Single-Center Retrospective and Descriptive Study of Hepatobiliary and Pancreatic Surgical Oncology during the COVID-19 Epidemic

Zhao

Zhang

et al. 2020

Preprint

Self Cite

View full text Add to dashboard Cite

Objective: In the battle against COVID-19, most medical resources in China have been directed to infected patients in Wuhan. Thus, patients with hepatobiliary pancreatic tumors who are not suffering from COVID-19 are often not given timely and effective anti-cancer treatments. In this study, we aimed to describe clinical characteristics, treatment, and outcomes of patients with hepatobiliary and pancreatic oncology from our department, which retained normal working during the COVID-19 epidemic. We also sought to formulate a set of standardized hospitalization and treatment processes.Methods: A retrospective and descriptive study was conducted involving patients hospitalized from February 1, 2020, to February 29, 2020 (Return to work after the Spring Festival), at our Department of Hepatobiliary and Pancreatic Surgical Oncology. Results: The study included 92 patients from 12 provinces in the north of China who underwent surgical resection at our Department of Hepatobiliary and Pancreatic Surgical Oncology during the COVID-19 epidemic. Robotic surgery was performed on 82% (75/92) of patients, while the rest underwent laparoscopic (2/92) and open surgery (15/92). Eighty-six patients had malignant tumor, and six had emergency benign diseases. Only five patients had severe pancreatic fistula, and three had biliary fistula after operation. Conclusions: The standardized hospitalization and treatment processes described in this study could prevent cross-infection of patients and still ensure timely treatment of patients with hepatobiliary and pancreatic cancers. These study findings will guide the management of surgical oncology departments and treatment of patients with hepatobiliary and pancreatic oncology during serious epidemics.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

A Single-Center Retrospective and Descriptive Study of Hepatobiliary and Pancreatic Surgical Oncology during the COVID-19 Epidemic

Zhao

Zhang

et al. 2020

Preprint

Self Cite

View full text Add to dashboard Cite

show abstract

“…Patient recruitment for one randomized control trials in China and one in the USA started in 2020, and results are expected for 2024. The international consensus statement on robotic pancreatic surgery published last year reveals that the level of evidence still remains moderate to low for the robotic platform [13] .…”

Section: Discussionmentioning

confidence: 99%

Robotic pancreaticoduodenectomy and splenopancreatectomy: technical aspects and review of literature

Tschuor¹,

Nagarkatti²,

Salibi³

et al. 2020

Mini-invasive Surg

View full text Add to dashboard Cite

Robotic pancreatic surgery provides several advantages. Since the first report of a robotic-assisted distal pancreatectomy in 2001, total pancreatectomies, pancreatic tumor enucleations, pancreaticoduodenectomy, central pancreatectomy and Appleby procedures have been performed, indicating a promising future. The aim of this article is to describe our experience of robotic pancreatic surgery including technical aspects for pancreaticoduodenectomy and distal pancreatectomy. The current literature on feasibility, safety and early postoperative outcomes will be discussed.

show abstract

“…Possible solutions may include centralisation of major pancreatic surgeries in a single centre and the adoption of robotic surgery that has been shown to shorten the learning curve, especially in PD. 71 Institutions that have been performing MIPS should be supported and incentivised to encourage more institutions and pancreatic surgeons to practise MIPS. The introduction of dedicated and structured training programmes and availability of expert proctors are also critical to promote LPS and RPS.…”

Section: Lps and Rps In Singaporementioning

confidence: 99%

Current Status of Laparoscopic and Robotic Pancreatic Surgery and Its Adoption in Singapore

Goh

Teo

2020

Ann Acad Med Singap

View full text Add to dashboard Cite

Despite the potential clinical advantages offered by laparoscopic pancreatic surgery (LPS), the main obstacle to its widespread adoption is the technically demanding nature of the procedure and its steep learning curve. LPS and robotic pancreatic surgery (RPS) have been proven to result in superior short-term perioperative outcomes and equivalent long-term oncological outcomes compared to the conventional open approach, with the caveat that they are performed by expert surgeons who have been trained to perform such procedures. The primary challenge faced by most pancreatic surgeons is the steep learning curve associated with these complex procedures and the need to undergo surgical training, especially with regards to laparoscopic and robotic pancreaticoduodenectomy. Current evidence suggests that RPS may help to shorten the lengthy learning curve required for LPS. More robust evidence—in the form of large randomised controlled trials—is needed to determine whether LPS and RPS can be safely adopted universally. Ann Acad Med Singapore 2020;49:377–83 Key words: Laparoscopic pancreatectomy, Laparoscopic pancreaticoduodenectomy, Minimally invasive pancreatic surgery, Robotic pancreatectomy, Robotic pancreaticoduodenectomy

show abstract

International consensus statement on robotic pancreatic surgery

Cited by 88 publications

References 116 publications

A Single-Center Retrospective and Descriptive Study of Hepatobiliary and Pancreatic Surgical Oncology during the COVID-19 Epidemic

A Single-Center Retrospective and Descriptive Study of Hepatobiliary and Pancreatic Surgical Oncology during the COVID-19 Epidemic

Robotic pancreaticoduodenectomy and splenopancreatectomy: technical aspects and review of literature

Current Status of Laparoscopic and Robotic Pancreatic Surgery and Its Adoption in Singapore

Contact Info

Product

Resources

About